Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NATURAL Study: Response-guided neoadjuvant strategy for high-risk locally advanced rectal cancer
jRCTs041250197Phase 2Not yet recruiting
- Start
- Mar 2026
- Countries
- 1
01
Overview
Phase 2, open-label trial in rectal cancer (3 arms). Primary endpoint: Primary: R0 resection rate in patients who omit chemoradiotherapy. Planned start Mar 2026; status: not yet recruiting.
02
Conditions
rectal cancer
Beyond the preview
Go deeper on jRCTs041250197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041250197.